Cargando…
MON-185 ACTH-Derived Peptide Antagonists as an Alternative Treatment Strategy for Congenital Adrenal Hyperplasia
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by different enzyme deficiencies in the steroid hormone synthesis leading to a disturbed cortisol biosynthesis. The medical treatment of CAH includes suboptimal ACTH-suppressing high glucocorticoid doses to reduce adrenal...
Autores principales: | Schubert, Tina, Nicke, Lennart, Schanze, André, Reisch, Nicole, Geyer, Armin, Koehler, Katrin, Huebner, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209623/ http://dx.doi.org/10.1210/jendso/bvaa046.589 |
Ejemplares similares
-
MON-175 Structural Instability as an Underlying Pathomechanism in Congenital Adrenal Hyperplasia
por: Meese, Nicolas, et al.
Publicado: (2020) -
MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia
por: Kusnetzow, Ana Karin, et al.
Publicado: (2020) -
MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia
por: Sappl, Andrea, et al.
Publicado: (2020) -
MON-171 Characterization of the Adrenal Gland and Adrenal Rest Tissues in Congenital Adrenal Hyperplasia
por: Kolli, Vipula, et al.
Publicado: (2020) -
MON-399 Congenital Adrenal Hyperplasia Newly Diagnosed in an Octogenarian
por: Nosova, Emily, et al.
Publicado: (2019)